1. Home
  2. CCEL vs ARAY Comparison

CCEL vs ARAY Comparison

Compare CCEL & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

N/A

Current Price

$4.81

Market Cap

32.7M

Sector

Health Care

ML Signal

N/A

Logo Accuray Incorporated

ARAY

Accuray Incorporated

N/A

Current Price

$0.14

Market Cap

31.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCEL
ARAY
Founded
1989
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
31.3M
IPO Year
2022
2006

Fundamental Metrics

Financial Performance
Metric
CCEL
ARAY
Price
$4.81
$0.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.5K
★ 11.2M
Earning Date
10-09-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 87.50
EPS
★ 0.23
N/A
Revenue
★ $25,384,279.00
N/A
Revenue This Year
N/A
$2.75
Revenue Next Year
N/A
$2.35
P/E Ratio
$21.78
★ N/A
Revenue Growth
★ 9.76
N/A
52 Week Low
$2.72
$0.12
52 Week High
$5.20
$1.51

Technical Indicators

Market Signals
Indicator
CCEL
ARAY
Relative Strength Index (RSI) 61.10 31.79
Support Level $3.20 N/A
Resistance Level N/A $0.29
Average True Range (ATR) 0.48 0.02
MACD 0.07 -0.01
Stochastic Oscillator 85.03 12.23

Price Performance

Historical Comparison
CCEL
ARAY

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.

Share on Social Networks: